1Brown RT,Freemen WS,Perrin JM,et al.Prevalence and assessment of attention-deficit/ hyperactivity disorder in primary care settings.Pediatrics,2001,107 (5):E43.
5Elia J. Drug treatment for hyperactive children:therapeutic guidelines. Drugs, 1993, 46:863-871.
6Greenhill LL. Pharmacologic treatment of attention deficit hyperactivity disorder. Psychiatr Clin North Am, 1992, 15:1-27.
7Spencer T, Biederman J, Wilens T, et al. Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry, 1996, 35:409-432.
8Gadow KD, Nolan EE, Sverd J, et al. Methylphenidate in aggressive-hyperactive boys: I.effects on peer aggression in public school settings. J Am Acad Child Adolesc Psychiatry, 1990, 29:710-718.
9Hoffman BB, Lefkowitz RJ. Catecholamines, sympathetic drugs, and adrenergic receptor antagonists. In: Hardman J, Limbird L, Molinoff P, eds. Goodman and gilman's the pharmacological basis of therapeutics. 9th ed. New York: MacMillan Publishing, 1996. 199-248.
10Wolraich ML, Doffing MA.Pharmacokinetic considerations in the treatment of attention-deficit hyperactivity disorder with methylphenidate. CNS Drugs, 2004, 18:243-250.
